BIG PHARMA WATCH: STUDY FINDS BIG PHARMA PROFITS THROUGH ANTI-COMPETITIVE KICKBACK SCHEMES CLOAKED AS CHARITY
Sep 9, 2022
Researchers Say Brand Name Drug Companies’ So-Called Patient Assistance… Read More
© 2026 CSRXP- All Rights Reserved
Updates
SECOND OPINION: AVIK ROY DEBUNKS BIG PHARMA’S INNOVATION RHETORIC
Sep 1, 2022
FREOPP President Explains Pharmaceutical Industry Arguments Are “Factually… Read More
DOSE OF REALITY: REPORT FINDS RX SPENDING CONTINUED TO RISE AS BIG PHARMA MAINTAINED BUSINESS-AS-USUAL APPROACH TO PRICE-GOUGING
Sep 1, 2022
Analysis Highlights How Escalating Prescription Drug Costs, Driven By Big… Read More
CSRXP APPLAUDS PRESIDENT BIDEN FOR TAKING MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE
Aug 16, 2022
Biden Administration and Congress Deliver Positive Progress on Longstanding… Read More
BIG PHARMA WATCH: DRUG COMPANIES ON PACE FOR RECORD 2022 LAUNCH PRICES
Aug 16, 2022
Analysis Finds Brand Name Manufacturers Bringing New Drugs to Market with… Read More
CSRXP: CONGRESS TAKES MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE, LOWERING DRUG PRICES FOR THE AMERICAN PEOPLE
Aug 12, 2022
Big Pharma Can No Longer Evade Accountability and Keep Prices High by Spending… Read More
ICYMI: OPINION: DRUG COMPANIES ARE WARNING THAT PRICING REFORM SPELLS DOOM. DON’T FALL FOR IT
Aug 8, 2022
Washington Post Op-ed Debunks Bogus Big Pharma Claims That Solutions to Lower… Read More
CSRXP APPLAUDS SENATE FOR MAJOR STEP TOWARD HOLDING BIG PHARMA ACCOUNTABLE AND LOWERING PRESCRIPTION DRUG PRICES
Aug 7, 2022
Drug Pricing Solutions in Inflation Reduction Act of 2022 Will Help Crack Down… Read More
BIG PHARMA EARNINGS WATCH: ABBVIE, ASTRAZENECA, AMGEN
Aug 5, 2022
Big Pharma Drugmakers Top Wall Street Estimates After Hiking Drug Prices… Read More
SECOND OPINION: PHRMA’S LAST-DITCH ATTEMPT TO DERAIL SOLUTIONS TO LOWER DRUG PRICES REHASHES DEBUNKED ARGUMENTS
Aug 5, 2022
Pharmaceutical Industry Attempts to Intimidate Lawmakers and Keep Prices High… Read More
ICYMI: CIVICASCRIPT BRINGS FIRST GENERIC DRUG TO MARKET TO PROVIDE MORE AFFORDABLE ALTERNATIVE TO HIGH-PRICED BIG PHARMA PRODUCTS
Aug 3, 2022
Private Sector and Non-Profit Partners Introduce Cancer Treatment That Can… Read More
BIG PHARMA EARNINGS WATCH: PFIZER, MERCK, BRISTOL MYERS SQUIBB, GLAXOSMITHKLINE AND SANOFI
Jul 29, 2022
Big Pharma Giants All Top Analysts’ Expectations as Pharmaceutical Industry… Read More